Skip to main content
logo
Nykode Therapeutics AS (OSL:NYKD)
Norway flag Norway · Delayed Price · Currency is NOK
3.440
+0.190 (5.85%)
Apr 1, 2026, 1:05 PM CET

Nykode Therapeutics AS Revenue

In the year 2025, Nykode Therapeutics AS had annual revenue of $453.00K USD, down -95.05%.

Revenue
$453.00K
Revenue Growth
-95.05%
P/S Ratio
245.99
Revenue / Employee
$7.68K
Employees
59
Market Cap
1.12B NOK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025453.00K-8.71M-95.05%
Dec 31, 20249.16M-4.17M-31.26%
Dec 31, 202313.32M4.29M47.56%
Dec 31, 20229.03M-26.74M-74.76%
Dec 31, 202135.77M-179.93M-83.42%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ArcticZymes Technologies ASA118.21M
Aqua Bio Technology ASA101.51M
Arctic Bioscience AS45.90M
Oncoinvent ASA20.00M
SoftOx Solutions AS15.58M
PCI Biotech Holding ASA4.69M
Thor Medical ASA839.00K
Lytix Biopharma AS377.00K
Revenue Rankings

Nykode Therapeutics AS News

More News